Proto-Oncogene Proteins c-hck
"Proto-Oncogene Proteins c-hck" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Members of the src-family tyrosine kinase family that are strongly expressed in MYELOID CELLS and B-LYMPHOCYTES.
| Descriptor ID |
D051572
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.800.590 D12.776.624.664.700.181
|
| Concept/Terms |
Proto-Oncogene Proteins c-hck- Proto-Oncogene Proteins c-hck
- Proto Oncogene Proteins c hck
- c-hck Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-hck
- c hck Proto Oncogene Proteins
- Tyrosine-Protein Kinase HCK
- Tyrosine Protein Kinase HCK
- Hematopoietic Cell Kinase
- Proto-Oncogene Protein c-hck
- Proto Oncogene Protein c hck
- c-hck, Proto-Oncogene Protein
- Proto-Oncogene Protein hck
- Proto Oncogene Protein hck
- c-hck Proteins
- c hck Proteins
- hck Proto-Oncogene Proteins
- Proto-Oncogene Proteins, hck
- hck Proto Oncogene Proteins
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-hck".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-hck".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-hck" by people in this website by year, and whether "Proto-Oncogene Proteins c-hck" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-hck" by people in Profiles.
-
Novel approaches to targeting MYD88 in Waldenstr?m macroglobulinemia. Expert Rev Hematol. 2017 08; 10(8):739-744.
-
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. 2016 06 23; 127(25):3237-52.
-
Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia. Leukemia. 2007 May; 21(5):906-11.
-
Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol Cell Biol. 2003 Jun; 23(11):3884-96.